Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18401,147,1.13 [0.84-1.51],0.4346013741047713
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19348,197,1.23 [0.98-1.55],0.0727365805755878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19122,1393,1.09 [0.98-1.20],0.1068616728164113
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,19362,436,1.08 [0.90-1.29],0.4034268009164506
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18726,3408,1.05 [0.98-1.12],0.1628952311620252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18709,3465,1.04 [0.98-1.11],0.2174239669176154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19123,1151,1.10 [0.99-1.23],0.0822698783019304
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19278,105,1.26 [0.93-1.71],0.1282460510853105
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17093,1013,1.04 [0.92-1.17],0.5145009308799855
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16480,1222,1.04 [0.93-1.17],0.4765162416120434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16125,258,0.99 [0.77-1.28],0.9438047364085864
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12618,2181,1.04 [0.96-1.13],0.3623731543579073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16082,392,1.30 [1.11-1.52],0.0009864959006382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19330,1358,1.14 [1.03-1.25],0.0095159186140976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,19429,503,1.04 [0.88-1.24],0.6244106724531533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18710,981,1.06 [0.94-1.20],0.3125541221146721
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19372,1118,1.05 [0.94-1.18],0.382565566241598
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18169,197,1.25 [0.99-1.57],0.0609294854896352
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19479,49,0.99 [0.56-1.76],0.9763624229115913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19232,978,1.04 [0.92-1.18],0.5123803493441634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19234,61,1.25 [0.84-1.88],0.2752390158775511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19428,108,1.23 [0.90-1.67],0.1919015222007349
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19414,94,1.15 [0.80-1.64],0.4508093023550369
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18107,378,0.99 [0.81-1.22],0.9554564580772476
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17980,251,1.27 [1.04-1.55],0.0188690189558814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18074,102,1.35 [1.01-1.80],0.0393375659259599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19464,45,0.35 [0.14-0.86],0.0225361489998842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19419,151,1.13 [0.85-1.51],0.3998072326022321
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral warts,19316,48,1.20 [0.74-1.95],0.4525399200181517
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19340,72,1.28 [0.89-1.84],0.1905675192192472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,19234,218,0.86 [0.64-1.16],0.3299897375388315
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19406,36,1.24 [0.73-2.10],0.4212721442927566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19392,41,0.71 [0.32-1.55],0.3866294764339507
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9195,71,0.68 [0.38-1.24],0.212632945379548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19094,1394,1.02 [0.92-1.13],0.6918396528832775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of meninges,19465,55,0.89 [0.50-1.59],0.6983263617128661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19402,68,1.19 [0.80-1.78],0.3926724090188173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19456,100,1.08 [0.74-1.57],0.6818935541213906
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of ovary,10232,65,1.30 [0.90-1.88],0.1634394515859145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19445,376,1.11 [0.92-1.33],0.2769480483688343
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Caecum,19458,318,0.86 [0.67-1.10],0.237555214510067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19357,73,1.15 [0.77-1.72],0.4954746167771081
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Descending colon,19444,217,0.80 [0.58-1.10],0.1735862741665023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,19402,342,0.98 [0.79-1.22],0.8420216865627212
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19346,579,1.02 [0.87-1.20],0.8156864543280484
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19438,445,1.10 [0.93-1.30],0.2827361013969127
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Carcinoma in situ of breast,7710,44,1.42 [0.95-2.14],0.0898501254737279
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7741,52,0.87 [0.47-1.59],0.6442066424528781
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13973,61,0.97 [0.58-1.62],0.902168546734316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",13993,81,0.69 [0.39-1.20],0.1883338466735228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19430,109,1.41 [1.09-1.82],0.0079127271038099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",19431,106,1.41 [1.09-1.83],0.0093158426341055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,10002,147,1.26 [0.98-1.63],0.0752589919934219
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lung cancer and mesothelioma,12433,421,0.93 [0.76-1.15],0.5249121815813576
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lymphoid leukaemia,13975,63,1.12 [0.72-1.74],0.60979990587627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14098,186,0.87 [0.63-1.20],0.3947209415645276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14169,257,0.87 [0.66-1.15],0.3314968594249309
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7826,99,1.10 [0.76-1.59],0.6052180409254455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14003,91,0.93 [0.60-1.44],0.7529438967356477
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14029,117,0.88 [0.59-1.32],0.5317437865667538
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14019,107,0.83 [0.54-1.29],0.4092827151813328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7802,75,0.58 [0.31-1.08],0.0849771811327996
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14022,110,0.71 [0.45-1.14],0.1609888421131585
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6987,802,0.78 [0.66-0.92],0.0036257971451742
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14026,114,1.19 [0.88-1.61],0.2618702273562527
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",13989,77,0.66 [0.36-1.20],0.1704644497661973
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14028,116,0.94 [0.64-1.38],0.7475428902333043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,19354,159,1.29 [1.02-1.64],0.0372874579517968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of trunk,19456,67,0.92 [0.55-1.55],0.7633348080226466
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanoma in situ,13959,100,0.69 [0.42-1.13],0.1393766537374615
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14013,101,0.66 [0.39-1.09],0.1064843930123165
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14080,168,0.82 [0.58-1.17],0.2725031108384396
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14207,295,0.94 [0.74-1.19],0.6073056799905197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14022,110,0.80 [0.51-1.24],0.3093983885416207
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,19332,144,1.33 [1.04-1.70],0.0226246295185094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15137,1225,0.90 [0.79-1.01],0.0814136501934934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15203,1291,0.91 [0.80-1.02],0.0972005068206102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19224,318,1.08 [0.88-1.32],0.478603444054768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17597,107,0.93 [0.63-1.39],0.7371679698607363
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18965,59,0.82 [0.45-1.49],0.5070320502308486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18878,2863,1.05 [0.98-1.13],0.160739633146681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18087,59,1.05 [0.64-1.72],0.8601837093767526
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19092,57,0.59 [0.29-1.21],0.1492803918426216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19088,1598,1.05 [0.96-1.16],0.2758952651436405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19086,1596,1.05 [0.96-1.16],0.2697013845731771
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17585,95,1.18 [0.83-1.67],0.3608213894108462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19182,1154,1.01 [0.90-1.14],0.8416697721320126
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19137,102,1.26 [0.92-1.71],0.1502587770428019
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18962,56,1.17 [0.74-1.83],0.5003723949436061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,18975,69,0.99 [0.61-1.60],0.9636712595211052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19321,286,0.99 [0.78-1.25],0.9026815292100764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19373,31,1.18 [0.64-2.17],0.5868778707127479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19268,233,0.88 [0.66-1.18],0.3986686743400434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18141,113,1.21 [0.88-1.65],0.2420227612323991
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13170,328,1.34 [1.13-1.58],0.0006183365930839
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18229,87,0.81 [0.49-1.34],0.403462614511859
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18231,89,0.84 [0.52-1.37],0.4851065377883858
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12902,60,1.26 [0.83-1.90],0.2757713807462808
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18147,42,0.38 [0.15-0.96],0.0408893943362858
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17534,261,0.99 [0.77-1.27],0.9506833232211078
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18854,737,0.90 [0.77-1.05],0.180426421669376
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18516,399,0.86 [0.69-1.08],0.1942062884121129
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18257,140,0.93 [0.65-1.33],0.6907352198172063
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19259,1154,1.01 [0.90-1.13],0.9055525180928314
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16480,1125,1.02 [0.90-1.14],0.8005421294837046
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12911,69,1.13 [0.74-1.74],0.5742556222438215
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17603,87,0.79 [0.48-1.30],0.3579499360454709
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13143,301,1.10 [0.90-1.36],0.351174684591604
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12891,49,1.81 [1.37-2.39],3.423918104513703e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16648,3806,0.99 [0.93-1.06],0.7916339392571936
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13069,227,0.78 [0.57-1.07],0.1290864982554225
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13432,590,1.09 [0.94-1.27],0.2377263487940696
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19433,298,1.10 [0.89-1.36],0.3824316168793499
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19252,117,1.12 [0.80-1.56],0.5083164327340777
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12965,123,0.97 [0.67-1.39],0.849912980194093
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12910,68,0.82 [0.47-1.43],0.4935110788005415
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18951,1435,1.04 [0.95-1.15],0.386299505322196
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13140,298,1.10 [0.91-1.34],0.3240650847497641
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13160,318,1.10 [0.89-1.35],0.3916970266415559
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13553,711,1.07 [0.93-1.23],0.3675022917785332
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12967,125,1.18 [0.87-1.60],0.2826911719581517
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19247,112,1.11 [0.79-1.57],0.5367781281633103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13583,741,1.09 [0.95-1.24],0.2275172791005685
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13372,530,0.98 [0.82-1.16],0.7910231888566046
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17332,59,1.12 [0.70-1.80],0.6458195355969354
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18186,5344,1.01 [0.96-1.07],0.6720871248204032
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17566,50,0.87 [0.47-1.62],0.6628441996076317
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17561,45,1.28 [0.81-2.00],0.2896881080097316
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19336,1535,0.96 [0.87-1.05],0.3842206353699918
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19334,1533,0.96 [0.87-1.06],0.4045730578022022
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17567,51,0.66 [0.32-1.36],0.2569459305522664
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19181,954,0.99 [0.87-1.13],0.8915820382696178
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14654,1812,1.04 [0.95-1.14],0.3915862236650892
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19468,242,0.91 [0.69-1.21],0.5216682793042635
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18209,92,0.87 [0.55-1.38],0.5490150550933747
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18327,100,0.89 [0.58-1.38],0.6153644973000701
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18370,143,0.84 [0.58-1.23],0.3786421691860105
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13001,159,0.99 [0.72-1.36],0.9534204992870045
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17153,150,1.13 [0.83-1.52],0.4419208683849805
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2068,81,0.99 [0.62-1.59],0.9695062859550782
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2202,248,1.04 [0.81-1.34],0.7656835708440857
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17070,67,1.18 [0.75-1.85],0.4805465264234191
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2035,49,1.04 [0.59-1.81],0.903630563613711
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18799,1796,1.01 [0.92-1.11],0.8149935427957513
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18609,492,0.91 [0.75-1.10],0.3084294839328267
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17635,362,1.09 [0.90-1.32],0.3564104210091184
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13721,879,1.17 [1.04-1.31],0.0074728879846552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19366,260,1.11 [0.89-1.38],0.3609603311157126
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18250,227,1.19 [0.94-1.50],0.1590179468517975
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,16885,1261,1.02 [0.91-1.14],0.7433883015816187
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18337,314,1.11 [0.90-1.37],0.3354589886406937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18091,68,1.03 [0.63-1.68],0.9104777155723248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18255,232,1.35 [1.11-1.64],0.002564838913843
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9947,2320,0.99 [0.91-1.07],0.7515999835438654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,AV-block,14946,545,1.00 [0.84-1.18],0.9882396810718698
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19408,464,0.89 [0.73-1.09],0.2636946909130113
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,7846,219,1.02 [0.78-1.33],0.8760342301708531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14572,171,0.87 [0.62-1.23],0.4281214464800632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14490,89,0.88 [0.55-1.42],0.6010423688463411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19475,59,0.73 [0.39-1.39],0.339037592063357
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,15667,1266,1.04 [0.93-1.15],0.5215876480695268
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17867,2263,1.06 [0.98-1.15],0.1292531052835993
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15777,7475,0.99 [0.94-1.03],0.5543525878332958
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18191,285,1.11 [0.90-1.37],0.3379945728335464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Endocarditis,14476,75,0.75 [0.43-1.32],0.3190269790557745
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19241,1345,1.02 [0.91-1.13],0.7593371929139145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,16804,6611,1.00 [0.95-1.05],0.972615683076782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16810,6617,1.00 [0.95-1.05],0.99252116684674
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19342,83,1.15 [0.80-1.67],0.4460344116019772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10426,233,0.88 [0.66-1.19],0.4079718211614968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10311,118,0.82 [0.53-1.27],0.3773163291674678
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,19330,1287,0.99 [0.88-1.10],0.8125846649482794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18434,119,0.61 [0.38-1.00],0.0485704201515152
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18014,2390,1.06 [0.98-1.14],0.1713881198046687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19071,651,1.03 [0.89-1.20],0.6811923391448289
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14823,422,1.05 [0.87-1.27],0.625342031353595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18926,879,1.09 [0.96-1.23],0.1829895584550924
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16380,756,1.14 [1.01-1.30],0.0376791727469371
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19368,158,1.04 [0.77-1.41],0.7960270880599487
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19441,343,1.22 [1.02-1.45],0.0288243868753992
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,17964,58,0.69 [0.35-1.36],0.2864179122184605
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other aneurysm,18105,82,1.16 [0.79-1.72],0.4443874502988199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,14887,486,1.01 [0.85-1.21],0.8835701181493041
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18132,109,1.12 [0.78-1.60],0.5511570069526206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18293,270,1.32 [1.09-1.59],0.0043330306435287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14586,185,1.23 [0.97-1.56],0.0835737478079602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other disorders of veins,17992,86,1.19 [0.82-1.71],0.3557309226837982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17943,37,1.04 [0.54-1.97],0.9150716290946708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17811,73,1.33 [0.95-1.86],0.0988682320843734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18044,138,1.07 [0.79-1.45],0.6448273830677382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15572,1171,1.10 [0.99-1.23],0.0640728274949217
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18093,50,0.87 [0.47-1.63],0.669785002276776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18617,594,1.12 [0.96-1.30],0.1485696407390159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18832,448,0.99 [0.82-1.20],0.9323593424239518
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18526,788,0.97 [0.84-1.12],0.6747325232873731
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7974,347,0.97 [0.78-1.20],0.7621111249825943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18471,477,1.15 [0.97-1.35],0.1030815144529048
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18260,354,1.05 [0.86-1.28],0.6165245266863124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18881,497,1.02 [0.86-1.22],0.8102588597428023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19393,785,1.06 [0.93-1.21],0.4069262387293397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14830,429,1.01 [0.83-1.23],0.9247061953764206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18828,444,0.99 [0.82-1.20],0.9543172094620568
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17950,212,0.94 [0.71-1.26],0.6831096407570736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19055,740,0.98 [0.85-1.14],0.823320178149417
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19044,773,0.99 [0.86-1.14],0.8810828622822464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18411,50,0.89 [0.48-1.65],0.7035470616801875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18106,83,0.72 [0.41-1.24],0.232277083297135
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18676,256,1.16 [0.93-1.43],0.1813296725435983
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18321,274,0.97 [0.76-1.24],0.8003217707324994
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,18323,417,1.07 [0.89-1.28],0.4839905684245266
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18039,98,0.94 [0.61-1.44],0.7681141170523356
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19242,783,1.03 [0.90-1.18],0.6537189979684287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19412,278,0.97 [0.76-1.24],0.8033519754768548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16750,1165,0.97 [0.86-1.10],0.6641234817104156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,19052,3467,1.01 [0.95-1.08],0.7269368433481915
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19387,327,0.89 [0.70-1.14],0.3507197860684351
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16759,1174,0.99 [0.88-1.11],0.8747776891829989
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,64,1.10 [0.69-1.76],0.681789802730312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,19059,974,1.01 [0.90-1.15],0.8188342924237075
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16789,1204,0.99 [0.88-1.11],0.8708593791634566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Vascular dementia,18784,192,1.03 [0.79-1.36],0.8146698780787355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Alzheimer disease,19476,492,0.89 [0.73-1.08],0.24531785111548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12148,92,0.84 [0.52-1.35],0.470088236630521
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Bell's palsy,17959,71,1.03 [0.65-1.62],0.9142106933916156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18297,409,0.90 [0.73-1.11],0.324124619461304
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral cysts,19116,204,1.04 [0.80-1.36],0.769741462338839
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19415,317,0.98 [0.78-1.24],0.8929542444834959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18795,69,1.09 [0.71-1.68],0.6910357948556851
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19460,60,1.10 [0.69-1.75],0.6810750836839784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",18981,69,0.97 [0.59-1.58],0.8899897903333969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,18258,242,0.70 [0.51-0.97],0.0311301680538592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19105,1089,0.96 [0.85-1.08],0.4958451194983578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19428,525,1.11 [0.95-1.30],0.1921006475618354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18931,2785,0.99 [0.92-1.07],0.8611550254680179
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Generalized epilepsy,19180,44,1.27 [0.80-2.01],0.3046763268022669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,19358,260,0.93 [0.72-1.21],0.5860517785255825
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hydrocephalus,18972,60,0.55 [0.27-1.12],0.0992271138632671
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19464,57,0.73 [0.38-1.39],0.3389166729965971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17950,62,1.11 [0.71-1.73],0.649874549075792
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17952,64,1.00 [0.61-1.64],0.9928115636209246
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Memory loss,18575,129,1.18 [0.88-1.59],0.2637594494647305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,18249,233,0.90 [0.68-1.19],0.466603086966449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19436,212,0.88 [0.66-1.19],0.4225053032318536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Motor neuron disease,12235,158,0.94 [0.68-1.31],0.7258136202729029
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19371,48,1.24 [0.78-1.98],0.36110502467102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18894,1006,0.89 [0.78-1.02],0.0981102116826681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,18254,3439,0.97 [0.91-1.04],0.4246568450065626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18964,238,0.97 [0.75-1.26],0.8127006374527712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18218,330,0.87 [0.68-1.11],0.2544016595776682
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19414,280,1.25 [1.03-1.50],0.0216128101949824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14791,786,0.94 [0.81-1.08],0.3755621320355442
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,18980,68,1.12 [0.72-1.74],0.6054250773944908
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19041,129,1.14 [0.83-1.55],0.4169281241743187
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19080,177,1.31 [1.05-1.63],0.0174160080019012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other facial nerve disorders,17966,78,1.01 [0.65-1.58],0.95450436215725
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other headache syndromes,18062,46,0.55 [0.24-1.24],0.1472344974672515
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,19384,472,1.10 [0.93-1.30],0.2484910466718803
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,18427,411,0.99 [0.82-1.20],0.9510983575275688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Parkinson's disease,19446,330,1.00 [0.80-1.24],0.9806130521950582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18950,38,1.22 [0.73-2.06],0.4466117495567909
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Restless leg syndrome,19475,77,1.21 [0.84-1.75],0.311049314282567
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,19293,354,1.01 [0.83-1.23],0.937546963179321
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19182,48,1.27 [0.81-2.00],0.3048560802572354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19464,178,0.88 [0.64-1.22],0.4508307813011036
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17946,58,0.70 [0.37-1.35],0.2908942940690969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19476,497,0.89 [0.73-1.08],0.2326339006744281
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18730,186,1.04 [0.79-1.37],0.7563398617325029
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18946,126,0.79 [0.52-1.19],0.257635939597883
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19114,478,1.13 [0.97-1.33],0.1200387924853651
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19273,219,0.97 [0.74-1.27],0.8268558885151933
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18445,52,1.08 [0.65-1.80],0.7609239054582089
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18426,33,1.39 [0.86-2.25],0.1801127292895941
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19374,61,1.00 [0.61-1.66],0.9913123679684572
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19213,192,1.05 [0.79-1.38],0.7506235423258701
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2039,52,1.16 [0.73-1.86],0.5282220583931387
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2513,92,1.05 [0.72-1.54],0.7968209359148571
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18909,89,0.90 [0.57-1.41],0.6329498327600438
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19242,1181,1.01 [0.90-1.13],0.8957388636832005
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19124,731,0.99 [0.85-1.14],0.8525652801058266
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18646,253,0.98 [0.76-1.27],0.8715213821300014
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19421,785,1.00 [0.87-1.15],0.9719115866890654
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19470,66,0.80 [0.45-1.42],0.4425596824901222
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19372,736,1.03 [0.90-1.19],0.6631268989962888
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19444,423,1.04 [0.87-1.26],0.642183479569661
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19377,188,0.93 [0.69-1.27],0.655055545027792
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18480,87,0.90 [0.57-1.42],0.6499259999559569
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18479,86,1.01 [0.66-1.54],0.9761021593787657
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18458,65,1.00 [0.61-1.64],0.9870549043413752
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19365,849,0.92 [0.80-1.06],0.2656919922248119
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18751,235,0.84 [0.62-1.12],0.233626795279623
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18690,54,0.84 [0.45-1.55],0.5753068594106328
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19125,104,1.09 [0.76-1.56],0.6341402851136848
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19351,330,1.04 [0.84-1.28],0.7159624620910219
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18820,184,0.92 [0.68-1.26],0.6041507424286658
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19306,117,0.92 [0.62-1.35],0.6569143651872444
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19068,552,0.93 [0.78-1.11],0.4407724898825038
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18952,132,1.12 [0.83-1.53],0.4556168094012621
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17450,2715,0.99 [0.92-1.07],0.847449306334575
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19315,294,1.03 [0.82-1.29],0.8201446871251907
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19461,159,0.83 [0.58-1.19],0.3063717914960305
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18844,451,1.01 [0.84-1.21],0.9312029609995996
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19097,76,0.88 [0.53-1.46],0.6172456700363382
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19463,59,0.86 [0.48-1.54],0.6053112403449965
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18499,106,1.14 [0.81-1.60],0.4592239317182017
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18545,152,0.99 [0.72-1.37],0.9690782585440691
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18195,134,0.86 [0.59-1.26],0.4413695103795315
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18679,43,0.78 [0.38-1.61],0.500636539472405
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18122,61,0.53 [0.26-1.07],0.0779209833710697
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18613,97,0.86 [0.55-1.35],0.5074704603760103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18759,243,0.88 [0.66-1.16],0.3588466969605659
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18517,124,1.08 [0.77-1.51],0.6538316738266756
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18138,77,1.44 [1.07-1.93],0.0149550610502204
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18165,104,0.71 [0.44-1.16],0.1716921786386797
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,16987,2252,0.97 [0.89-1.06],0.536071323237643
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18472,79,1.20 [0.82-1.74],0.3474369238694257
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19235,415,0.94 [0.77-1.15],0.5593570293962078
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18884,64,0.76 [0.42-1.39],0.3786869082575066
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),18980,160,0.73 [0.49-1.07],0.1069727006449633
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19280,91,0.65 [0.38-1.12],0.119945165575391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19440,120,1.13 [0.82-1.56],0.442984227610899
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19368,95,1.04 [0.71-1.54],0.8309904369656339
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19246,57,1.14 [0.72-1.80],0.5808576690410069
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19249,60,0.89 [0.51-1.55],0.6798065529178412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19383,984,0.85 [0.73-0.98],0.0240074345102592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19147,748,0.89 [0.76-1.05],0.1665200752076255
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18523,124,0.60 [0.37-0.98],0.0396918837322446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18471,72,1.03 [0.65-1.62],0.9123606205105784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute pharyngitis,19310,52,0.75 [0.39-1.47],0.4050495087232406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19408,150,1.05 [0.77-1.43],0.7520191768092783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19308,50,1.12 [0.68-1.85],0.6510887733302437
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza,17314,122,1.23 [0.92-1.65],0.1694827950489266
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17311,119,1.20 [0.88-1.63],0.2485651397407294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12093,81,1.22 [0.85-1.76],0.2809991315606548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic rhinitis,19392,198,0.93 [0.69-1.26],0.6410045329252251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13161,1462,0.95 [0.85-1.06],0.3477071307133823
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13458,1446,0.95 [0.85-1.06],0.3210273932802408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19049,149,0.94 [0.66-1.33],0.722586332370271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17275,83,1.06 [0.69-1.62],0.800656230415872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bronchiectasis,16308,428,1.10 [0.92-1.31],0.2766480053800192
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15939,59,1.05 [0.65-1.72],0.8339407724339235
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18537,2657,1.00 [0.92-1.08],0.965003315118239
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18448,66,0.83 [0.48-1.45],0.523896058138899
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,18493,111,1.06 [0.75-1.52],0.7313408184444896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19234,1351,1.01 [0.91-1.13],0.789456679339683
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,18451,69,0.59 [0.31-1.12],0.108546414964604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17673,5065,0.99 [0.94-1.05],0.7320349612226558
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18670,288,0.88 [0.68-1.14],0.3487174884572873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,17980,97,1.03 [0.70-1.53],0.8780699227091728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Emphysema,16247,367,1.06 [0.87-1.29],0.5414967390525534
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18361,392,1.15 [0.97-1.37],0.1174966821548932
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19255,2063,1.06 [0.97-1.15],0.1919116929148891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,18395,426,1.18 [1.01-1.39],0.0406982528950876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Later onset COPD,19030,1254,1.01 [0.91-1.13],0.8318179174311308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19461,372,0.87 [0.69-1.09],0.2253302500325209
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,18466,84,0.79 [0.48-1.32],0.3729422180457719
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19237,1041,0.94 [0.83-1.07],0.3869239544273021
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,19236,2214,1.04 [0.96-1.13],0.2863999944917617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19016,634,0.95 [0.80-1.11],0.5033898004708374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other pleural conditions,17072,50,1.00 [0.58-1.74],0.9950615108512668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19360,504,1.26 [1.10-1.45],0.0010003497936477
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19365,1416,1.09 [0.99-1.21],0.0678985442898182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,18122,1100,0.97 [0.86-1.10],0.6629638866494045
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural plaque,17238,216,0.93 [0.70-1.23],0.6035251573281906
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19020,1828,1.05 [0.96-1.15],0.2596765490088045
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19367,278,0.88 [0.68-1.15],0.3495379524416221
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumothorax,17172,150,0.86 [0.60-1.24],0.4276877559970637
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pollen allergy,19467,166,0.80 [0.56-1.15],0.2280775091521831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,18932,76,1.53 [1.15-2.03],0.0031062860689332
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12069,57,0.98 [0.57-1.69],0.9434850966089134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19223,1027,0.95 [0.83-1.08],0.4060578409413469
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18581,199,0.92 [0.69-1.25],0.6054961775264112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Viral pneumonia,17435,243,1.15 [0.92-1.45],0.2167885767018656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19061,195,1.18 [0.93-1.52],0.1770123387827107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6296,97,0.79 [0.49-1.29],0.3549326130356116
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12455,53,1.22 [0.78-1.90],0.3817164087741156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,19375,109,0.98 [0.67-1.44],0.9079826711865304
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute gastritis,13619,82,1.12 [0.76-1.66],0.5756592717430584
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,17788,164,0.82 [0.57-1.17],0.2660327991150321
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute peritonitis,19080,92,0.91 [0.58-1.42],0.678544302289358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18648,48,1.07 [0.62-1.85],0.8099004146212132
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Barrett oesophagus,13954,417,0.91 [0.74-1.12],0.3588007728575032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17745,121,0.91 [0.62-1.34],0.6425555003136941
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19132,121,0.91 [0.62-1.34],0.6475627507434841
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,17800,176,1.01 [0.75-1.35],0.9630072379435388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,18499,875,0.95 [0.83-1.09],0.4726921870599067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,13823,286,0.89 [0.69-1.15],0.3692683597910756
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17668,44,0.97 [0.53-1.76],0.9213133529332468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19365,106,0.85 [0.55-1.31],0.463899058850284
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,18034,103,1.57 [1.25-1.98],0.0001219897838004
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Collagenous colitis,18012,88,0.95 [0.61-1.46],0.8044724285654102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19377,140,0.84 [0.58-1.24],0.3847164804202523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,19241,1719,0.96 [0.87-1.06],0.3691025774686208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,17991,67,0.88 [0.52-1.50],0.6363147630258073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19184,52,0.94 [0.53-1.68],0.8462816399891991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17985,61,0.84 [0.47-1.49],0.5538057999729917
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,18954,159,0.97 [0.71-1.35],0.8728009692349762
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16880,2138,1.03 [0.94-1.12],0.5616217613622725
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,19401,135,1.00 [0.72-1.41],0.9865095939898868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,19381,781,0.97 [0.84-1.12],0.6955272311460873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17361,3824,0.97 [0.91-1.04],0.3697526294650582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19193,398,1.05 [0.86-1.27],0.6469131748723917
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19402,414,1.00 [0.82-1.21],0.9696328640502416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18872,77,1.13 [0.76-1.68],0.5470324673907339
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18768,46,1.50 [1.05-2.15],0.0265784779701003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19205,1274,1.17 [1.06-1.28],0.0018306011607611
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of tongue,18779,77,0.80 [0.47-1.35],0.3995432977800508
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18891,1267,0.95 [0.85-1.07],0.4272053506477509
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15579,3177,1.01 [0.95-1.09],0.6988322139921057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,13736,199,0.69 [0.49-0.99],0.0455883348777639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19393,160,0.71 [0.48-1.05],0.0892400903778348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19448,19,0.92 [0.35-2.41],0.8673248300124385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18724,124,0.95 [0.65-1.36],0.7629744145943099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12496,94,0.73 [0.43-1.21],0.2220666068419243
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,14013,476,0.93 [0.77-1.13],0.489819337434028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,13894,357,1.04 [0.84-1.27],0.739991854859669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15754,2217,0.93 [0.85-1.01],0.0994340697063623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14073,536,0.95 [0.79-1.14],0.5667911445055311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14141,6909,1.00 [0.95-1.05],0.9997183533531884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,18978,1047,1.11 [0.99-1.24],0.0820904854715393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18839,44,1.26 [0.79-2.01],0.3343492308149604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13223,981,1.05 [0.93-1.18],0.430829412163184
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18656,56,1.09 [0.68-1.76],0.7150289722071497
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,17771,3029,1.04 [0.97-1.12],0.2457675556907636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,19450,18,0.86 [0.31-2.44],0.7836314676075606
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impaction of intestines,12464,62,1.32 [0.93-1.89],0.1237358523113459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,15659,917,1.01 [0.89-1.15],0.8416797457231082
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14839,97,1.18 [0.83-1.66],0.3607231347838178
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12501,99,0.96 [0.64-1.45],0.8579725663854187
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18053,122,1.46 [1.16-1.85],0.0014221005591358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12830,428,1.09 [0.92-1.30],0.3350786726540986
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19453,277,0.95 [0.75-1.21],0.6895036515688036
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18583,659,1.05 [0.90-1.21],0.531959983298147
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18839,915,1.02 [0.90-1.16],0.7778221835840091
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13719,182,0.79 [0.56-1.12],0.1914313210763913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,14126,589,0.99 [0.84-1.17],0.926087288801807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19428,113,1.15 [0.83-1.59],0.4074404242521847
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14812,70,1.18 [0.79-1.76],0.4091805488425497
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13560,1158,1.04 [0.93-1.16],0.4817614939283459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17921,297,0.91 [0.71-1.16],0.4551186133639368
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17745,121,1.01 [0.71-1.44],0.9555413785299872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,14009,1607,1.03 [0.94-1.13],0.548325299587044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,17545,5143,1.02 [0.97-1.08],0.4427522512275835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18752,181,1.14 [0.88-1.47],0.328463325486336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,19246,646,1.01 [0.86-1.18],0.910355865292516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14177,640,0.97 [0.83-1.14],0.7215485388984715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17800,176,0.92 [0.67-1.27],0.6255260078681589
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19337,349,0.99 [0.80-1.22],0.9185164757581205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14461,924,1.06 [0.94-1.20],0.3311198865312055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18990,1059,1.10 [0.98-1.23],0.0912413922901161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18944,149,1.24 [0.96-1.61],0.104040130354911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14158,1756,0.98 [0.89-1.07],0.6219841053983437
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15339,1802,1.02 [0.93-1.12],0.6940258511906944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18696,96,1.03 [0.69-1.53],0.8884554590864442
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18737,813,1.03 [0.90-1.18],0.6581112011496821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12767,365,1.06 [0.87-1.28],0.554587487319754
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19445,23,0.75 [0.28-2.04],0.5711040543978493
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12914,512,1.14 [0.98-1.32],0.0941299851050623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18068,137,1.30 [1.00-1.68],0.0466016639658188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19464,43,1.18 [0.71-1.96],0.5230907299593672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18789,83,1.00 [0.65-1.53],0.9921921500604084
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Toxic colitis,17993,69,1.13 [0.75-1.71],0.562046496169582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13830,293,0.97 [0.77-1.23],0.8312638401228521
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,18058,134,0.98 [0.69-1.38],0.905013410636339
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18031,107,0.99 [0.68-1.45],0.9521956098567538
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,14949,207,0.78 [0.56-1.09],0.1498853099970488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12603,201,0.69 [0.49-0.99],0.0421770180689431
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,14968,226,1.16 [0.92-1.47],0.2153615675082885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Volvulus,12477,75,1.60 [1.24-2.07],0.0003533238786832
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19388,340,1.18 [0.98-1.41],0.0730890423671963
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19174,61,0.94 [0.56-1.59],0.8315624842988607
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17389,142,1.05 [0.77-1.45],0.7503998680882544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18960,686,1.11 [0.96-1.27],0.1549658422294416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18391,117,1.32 [0.99-1.75],0.0559428877784532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17730,483,1.16 [0.99-1.35],0.0711309671018202
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19186,259,1.06 [0.84-1.33],0.649841175432343
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19385,458,1.15 [0.97-1.35],0.0978827584211073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18970,43,1.15 [0.68-1.93],0.6015763746084504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18127,3082,1.04 [0.97-1.11],0.2847790508068119
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19109,369,1.08 [0.90-1.31],0.4100041645343829
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,18997,257,1.02 [0.80-1.30],0.8712453009509412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19158,884,1.15 [1.03-1.30],0.0173087273575629
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19459,51,1.14 [0.70-1.86],0.5926903629242951
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17302,55,1.37 [0.94-1.99],0.099764986781524
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18793,53,1.23 [0.80-1.92],0.3478715283266643
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19174,247,1.05 [0.82-1.33],0.7056014280924985
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17748,501,0.89 [0.73-1.08],0.2371127679331379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17326,79,0.85 [0.51-1.41],0.5269612059970289
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19407,72,1.29 [0.91-1.84],0.1581607265662581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18448,174,1.21 [0.94-1.57],0.1439995881790819
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19300,187,0.88 [0.64-1.21],0.415890539616861
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,18999,72,1.43 [1.06-1.94],0.0191080447670272
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17307,60,0.77 [0.42-1.43],0.4110500553418406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18960,1713,1.06 [0.96-1.16],0.2461084082258727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17786,539,0.89 [0.74-1.08],0.2357092058393148
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17328,81,0.92 [0.57-1.48],0.7265679890414038
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19398,285,0.96 [0.75-1.22],0.7403420760134367
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,18992,65,1.21 [0.80-1.83],0.3596971796182404
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19346,233,0.91 [0.69-1.20],0.4970255506621257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19416,368,1.14 [0.95-1.36],0.1598322248722634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17354,107,1.08 [0.76-1.54],0.668086397069461
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17521,274,0.91 [0.70-1.17],0.4588700170712942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19405,357,1.15 [0.96-1.38],0.1329801451108355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17505,258,1.32 [1.11-1.58],0.0018348576337513
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19454,119,1.13 [0.81-1.56],0.4748430232461147
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16245,66,1.06 [0.66-1.70],0.8093169260227011
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17184,5378,0.98 [0.93-1.03],0.4384523383300052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16004,4198,0.96 [0.90-1.02],0.2093181138526032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16224,45,0.97 [0.52-1.80],0.9229232390887736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16229,118,0.79 [0.51-1.22],0.279506501125539
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16268,157,1.25 [0.97-1.60],0.0844703558443309
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19256,50,0.56 [0.26-1.22],0.1456442294821474
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16235,124,0.88 [0.59-1.30],0.5116073162125192
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13057,1251,0.86 [0.76-0.97],0.0157582055131848
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19290,209,0.80 [0.58-1.10],0.1630942051280373
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16574,463,1.10 [0.93-1.30],0.2507798592108845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15786,6725,0.99 [0.94-1.04],0.6074204915546841
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17398,102,1.07 [0.75-1.54],0.7038803825764819
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16326,147,1.08 [0.79-1.47],0.6209602964127512
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16610,431,0.89 [0.72-1.10],0.27565232622198
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18690,2579,1.01 [0.93-1.09],0.8039279552576979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16446,267,0.95 [0.74-1.22],0.6841311392119604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16300,121,1.24 [0.94-1.65],0.1314813330538827
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16278,99,1.02 [0.70-1.51],0.9005062331539481
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18823,87,0.95 [0.61-1.47],0.8049464660302449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13485,1679,0.99 [0.90-1.09],0.7997722399487525
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12438,632,1.08 [0.93-1.25],0.3008157765874447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19398,626,1.06 [0.92-1.23],0.4081584307928563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11865,59,1.25 [0.84-1.86],0.2788283394472798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12066,260,0.70 [0.52-0.96],0.0244145051388109
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16403,224,0.96 [0.73-1.26],0.7612693653739853
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12216,410,1.04 [0.86-1.25],0.6844417593265747
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16174,63,1.09 [0.68-1.75],0.7274856373895652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16671,560,0.92 [0.77-1.10],0.3761655659878646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16364,253,0.84 [0.64-1.12],0.2393404689348977
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12190,384,1.04 [0.86-1.26],0.7055339528786375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16237,58,0.90 [0.51-1.58],0.7130035635395804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16227,48,0.57 [0.26-1.26],0.1666015701270686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17361,65,0.86 [0.49-1.51],0.597590370504776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19122,1826,1.04 [0.95-1.13],0.4384429553470137
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18584,1288,1.03 [0.93-1.15],0.5793972806960317
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19335,452,1.13 [0.95-1.33],0.1571038591596259
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14406,2600,0.98 [0.91-1.06],0.6319805836546266
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11845,39,1.19 [0.71-1.99],0.50542377202486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16263,84,0.88 [0.55-1.42],0.6043437689791302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11872,66,0.73 [0.40-1.33],0.301565269768403
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11919,113,1.06 [0.75-1.50],0.734064892586391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17501,205,1.06 [0.82-1.38],0.6554028362859705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17697,401,1.11 [0.93-1.33],0.2520452793579757
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19459,88,0.97 [0.63-1.50],0.8877091889650046
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17742,1631,0.98 [0.89-1.09],0.7152625608445136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16238,59,0.59 [0.30-1.19],0.1435730179242814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11931,125,0.78 [0.52-1.18],0.2416659545130702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16766,655,0.91 [0.77-1.08],0.2922172737749844
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13619,1813,0.93 [0.84-1.02],0.1392441086389385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18841,105,1.08 [0.76-1.54],0.6536413681419153
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19469,58,0.98 [0.58-1.65],0.928966311818184
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16245,66,1.04 [0.65-1.66],0.872660966391206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17291,1112,1.07 [0.96-1.20],0.2083743135968326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16264,85,1.14 [0.78-1.67],0.4901284170225594
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13542,1736,0.96 [0.87-1.06],0.4328262129667891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17399,103,1.09 [0.75-1.56],0.6567467873526127
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16206,27,0.60 [0.22-1.66],0.3259953783971479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16273,162,1.19 [0.91-1.55],0.1935515311317006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16735,556,1.14 [0.98-1.32],0.0957149266319961
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19154,418,1.01 [0.84-1.23],0.8856987596692878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16655,544,0.97 [0.81-1.15],0.7141981293565529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19346,447,1.13 [0.95-1.33],0.1667894918522487
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19457,57,0.87 [0.48-1.56],0.635569123223102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16318,139,0.85 [0.58-1.24],0.3888826901350074
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15159,718,0.97 [0.83-1.13],0.6824792133366955
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16712,533,1.02 [0.86-1.20],0.8486438641736888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16420,241,0.97 [0.74-1.25],0.7932068226046709
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11869,63,0.93 [0.55-1.55],0.7700550615020771
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14408,2602,1.00 [0.93-1.08],0.9524717968339984
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12503,697,0.90 [0.77-1.06],0.2147453591478783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19048,312,0.81 [0.62-1.05],0.108225804399824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19430,59,1.00 [0.59-1.67],0.9892366856346976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17262,58,0.89 [0.49-1.60],0.6882217782181734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11865,59,0.98 [0.58-1.64],0.9256559614179688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16200,89,0.96 [0.62-1.48],0.8466924182022536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12265,459,1.12 [0.95-1.32],0.1704409942123751
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16460,281,0.87 [0.66-1.13],0.2883684803373229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16348,237,0.98 [0.75-1.27],0.8592414287184215
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16322,211,1.10 [0.86-1.41],0.4398059772311263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13729,60,1.04 [0.64-1.68],0.875418738152571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19460,60,0.86 [0.49-1.53],0.6173118463851575
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16645,466,0.99 [0.83-1.19],0.9545266114771026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],18820,84,1.45 [1.10-1.91],0.0081895350452258
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18378,2199,1.01 [0.93-1.10],0.7479343066612084
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16300,121,1.31 [1.00-1.72],0.0494064097398422
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16682,571,1.03 [0.87-1.21],0.7530701198255463
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18313,221,1.10 [0.87-1.40],0.4237054893992181
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16308,197,1.18 [0.93-1.50],0.1776325206445869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17736,1625,1.02 [0.92-1.12],0.7367303163366741
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17170,1059,1.01 [0.89-1.14],0.9058284787475632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16227,48,0.94 [0.52-1.72],0.8451596080643475
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18843,107,1.36 [1.04-1.78],0.0232457432084028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16324,145,0.84 [0.58-1.22],0.3542782950180567
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16256,77,1.41 [1.03-1.94],0.0303586843295793
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11865,59,0.94 [0.55-1.61],0.830408148833991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18368,1782,1.08 [0.99-1.18],0.0942485958896578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7867,22,1.02 [0.45-2.35],0.955862782042916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9980,27,1.08 [0.53-2.20],0.8395679485628726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19205,260,1.10 [0.88-1.37],0.4129535089572513
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19035,90,0.89 [0.56-1.40],0.6147746859029379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18294,1708,1.10 [1.00-1.20],0.0402143173673798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19296,85,1.15 [0.79-1.66],0.4627371133911608
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19258,325,1.13 [0.93-1.37],0.2246817789963611
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,16346,245,1.05 [0.82-1.33],0.7219714781169835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dialysis,16653,67,1.28 [0.86-1.91],0.2275722111657203
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8514,1767,0.93 [0.84-1.03],0.1700741010052585
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10060,107,1.31 [0.97-1.75],0.0761824535760004
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,7878,33,1.07 [0.55-2.05],0.8448094427273577
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8329,484,0.98 [0.82-1.18],0.8461247080235895
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16088,5172,1.03 [0.98-1.09],0.233761500031552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19278,67,1.19 [0.81-1.75],0.3673395256614498
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,6850,103,0.65 [0.39-1.09],0.1009706687742017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16618,273,0.89 [0.69-1.16],0.4006038838926964
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8243,1496,0.93 [0.83-1.04],0.1920008008865514
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10114,133,1.11 [0.81-1.53],0.5161305580073308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6853,106,0.71 [0.44-1.14],0.15578649951977
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16171,70,0.68 [0.37-1.24],0.2063770781707864
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8708,863,1.05 [0.92-1.19],0.4803732414810394
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6799,52,0.92 [0.51-1.67],0.7865547082431428
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7877,32,0.87 [0.39-1.91],0.7224462809838494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19470,73,0.88 [0.53-1.47],0.6307751109645832
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19466,67,1.53 [1.14-2.06],0.0046859797221633
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18477,2376,0.98 [0.91-1.07],0.6885086682631778
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16886,785,0.95 [0.82-1.10],0.507815626100613
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9998,45,1.48 [0.99-2.20],0.0534892093984276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19418,485,1.09 [0.92-1.28],0.3227833096623008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6869,122,0.91 [0.61-1.35],0.6282472357453255
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6879,132,0.78 [0.51-1.18],0.2339764909877912
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6870,123,0.81 [0.53-1.24],0.3319334890280636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19447,68,0.83 [0.48-1.44],0.5039030003288045
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17950,1849,1.00 [0.91-1.09],0.960190610559804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10051,70,1.13 [0.74-1.73],0.565713869329872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7909,64,0.71 [0.38-1.33],0.2869364820398545
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7978,133,0.93 [0.64-1.35],0.7074183726900922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7891,46,1.10 [0.66-1.82],0.7194087450404895
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7930,85,0.54 [0.30-0.99],0.0475760564097068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16665,320,0.92 [0.73-1.17],0.5208865242398228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19091,158,0.92 [0.65-1.29],0.619099888483666
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7950,105,1.34 [1.01-1.78],0.0408147609906016
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7866,21,0.71 [0.24-2.09],0.537749953287652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8026,181,1.14 [0.87-1.48],0.3401061348980674
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7927,82,0.87 [0.53-1.41],0.566411149354099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8022,177,1.03 [0.77-1.38],0.8582443586123064
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19256,45,0.95 [0.52-1.76],0.8816616193457587
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6871,124,1.32 [1.01-1.71],0.0408129052348091
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19279,2934,1.06 [0.99-1.14],0.0790434238945316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16420,75,1.33 [0.94-1.88],0.1040538049848462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16719,133,0.84 [0.57-1.26],0.402833244799464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,18978,33,0.84 [0.39-1.85],0.6723982310249761
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16326,225,1.16 [0.92-1.46],0.2199670708325804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19282,337,1.06 [0.86-1.30],0.5905360270279606
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7879,34,0.88 [0.40-1.93],0.758815142537496
